SynopsisThe global Medical Braces market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. According to our research, the global market for medical devices is estimated.....
SynopsisThe global Intra Aortic Counterpulsation Device market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Intra Aortic Counterpulsation Device in various end u.....
SynopsisMagnetoencephalography (MEG) is a non-invasive technique for investigating human brain activity. It allows the measurement of ongoing brain activity on a millisecond-by-millisecond basis, and it shows where in the brain activity is produced. The global M.....
SynopsisAtrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and its incidence and prevalence are increasing year by year. Atrial fibrillation mainly increases the risk of stroke by 2 to 7 times, increases the risk of death by 2 times, and serious.....
Synopsis Healthcare analytics is the branch of analysis that focuses on offering insights into hospital management, patient records, costs, diagnoses, and more. The field covers a broad swath of thehealthcare industry, offering insights on bo.....
SynopsisLorazepam is used to treat anxiety disorders and seizure disorders. The global Lorazepam Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. .....
SynopsisThe global Chlorhexidine Gluconate market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026. This report focuses on Chlorhexidine Gluconate volume and value at the g.....
SynopsisOcular administration of drug isprimarily associated with the need totreat ophthalmic diseases. The global Ocular Drug Delivery Technology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % d.....
SynopsisPegademase bovine Injection is a modified enzyme used for enzyme replacement therapy for the treatment of severe combined immunodeficiency. The global Pegademase Bovine market was valued at US$ 79 million in 2023 and is anticipated to reach US$ 103.7 mil.....
SynopsisThe major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age. The globa.....
